{
"instance": {
"mdxl_10q.htm": {
"axisCustom": 0,
"axisStandard": 7,
"contextCount": 106,
"dts": {
"calculationLink": {
"local": [
"mdxl-20220630_cal.xml"
]
},
"definitionLink": {
"local": [
"mdxl-20220630_def.xml"
]
},
"inline": {
"local": [
"mdxl_10q.htm"
]
},
"labelLink": {
"local": [
"mdxl-20220630_lab.xml"
]
},
"presentationLink": {
"local": [
"mdxl-20220630_pre.xml"
]
},
"schema": {
"local": [
"mdxl-20220630.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
"https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
"https://xbrl.sec.gov/country/2022/country-2022.xsd",
"https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
]
}
},
"elementCount": 283,
"entityCount": 1,
"hidden": {
"http://fasb.org/us-gaap/2022": 38,
"http://medixall.com/20220630": 14,
"http://xbrl.sec.gov/dei/2022": 5,
"total": 57
},
"keyCustom": 31,
"keyStandard": 151,
"memberCustom": 9,
"memberStandard": 8,
"nsprefix": "mdxl",
"nsuri": "http://medixall.com/20220630",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"b",
"p",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "00000001 - Document - Cover",
"role": "http://medixall.com/role/Cover",
"shortName": "Cover",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"b",
"p",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000010 - Disclosure - Going Concern",
"role": "http://medixall.com/role/GoingConcern",
"shortName": "Going Concern",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000011 - Disclosure - Summary of Significant Accounting Policies",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPolicies",
"shortName": "Summary of Significant Accounting Policies",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000012 - Disclosure - Right-to-use Intellectual Property",
"role": "http://medixall.com/role/Right-to-useIntellectualProperty",
"shortName": "Right-to-use Intellectual Property",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PreferredStockTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000013 - Disclosure - Preferred Stock",
"role": "http://medixall.com/role/PreferredStock",
"shortName": "Preferred Stock",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PreferredStockTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000014 - Disclosure - Related Party Transactions",
"role": "http://medixall.com/role/RelatedPartyTransactions",
"shortName": "Related Party Transactions",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000015 - Disclosure - Senior Convertible Debentures and Warrants",
"role": "http://medixall.com/role/SeniorConvertibleDebenturesAndWarrants",
"shortName": "Senior Convertible Debentures and Warrants",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000016 - Disclosure - Summary of Significant Accounting Policies (Policies)",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
"shortName": "Summary of Significant Accounting Policies (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000017 - Disclosure - Summary of Significant Accounting Policies (Tables)",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPoliciesTables",
"shortName": "Summary of Significant Accounting Policies (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000018 - Disclosure - Right-to-use Intellectual Property (Tables)",
"role": "http://medixall.com/role/Right-to-useIntellectualPropertyTables",
"shortName": "Right-to-use Intellectual Property (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000019 - Disclosure - Related Party Transactions (Tables)",
"role": "http://medixall.com/role/RelatedPartyTransactionsTables",
"shortName": "Related Party Transactions (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Cash",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
"role": "http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Cash",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000020 - Disclosure - Senior Convertible Debentures and Warrants (Tables)",
"role": "http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsTables",
"shortName": "Senior Convertible Debentures and Warrants (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"mdxl:AssetAcquisitionDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-01-17",
"decimals": "0",
"first": true,
"lang": null,
"name": "mdxl:IntellectualPropertyValue",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000021 - Disclosure - Asset Acquisition (Details Narrative)",
"role": "http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"shortName": "Asset Acquisition (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"mdxl:AssetAcquisitionDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-01-17",
"decimals": "0",
"first": true,
"lang": null,
"name": "mdxl:IntellectualPropertyValue",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:RetainedEarningsAccumulatedDeficit",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000022 - Disclosure - Going Concern (Details Narrative)",
"role": "http://medixall.com/role/GoingConcernDetailsNarrative",
"shortName": "Going Concern (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-07-012022-08-23_us-gaap_SubsequentEventMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:ProceedsFromConvertibleDebt",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000023 - Disclosure - Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details)",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails",
"shortName": "Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30_us-gaap_SeriesAPreferredStockMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000024 - Disclosure - Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details)",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails",
"shortName": "Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
"us-gaap:EarningsPerSharePolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30_us-gaap_SeriesAPreferredStockMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
"role": "http://medixall.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
"shortName": "Summary of Significant Accounting Policies (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock",
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:FiniteLivedIntangibleAssetsGross",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000026 - Disclosure - Right-to-use Intellectual Property (Schedule of Right-to-use Intellectual Property) (Details)",
"role": "http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails",
"shortName": "Right-to-use Intellectual Property (Schedule of Right-to-use Intellectual Property) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock",
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:FiniteLivedIntangibleAssetsGross",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"mdxl:ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock",
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000027 - Disclosure - Right-to-use Intellectual Property (Schedule of amortization expense for right-to-use intellectual property) (Details)",
"role": "http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails",
"shortName": "Right-to-use Intellectual Property (Schedule of amortization expense for right-to-use intellectual property) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"mdxl:ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock",
"us-gaap:IntangibleAssetsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"us-gaap:PreferredStockSharesIssued",
"span",
"span",
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:PreferredStockSharesOutstanding",
"reportCount": 1,
"unitRef": "Shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000028 - Disclosure - Preferred Stock (Details Narrative)",
"role": "http://medixall.com/role/PreferredStockDetailsNarrative",
"shortName": "Preferred Stock (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"us-gaap:PreferredStockTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember",
"decimals": "INF",
"lang": null,
"name": "mdxl:ConvertiblePreferredStockTotalSharesIssuedUponConversion",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:AccountsPayableRelatedPartiesCurrent",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000029 - Disclosure - Related Party Transactions (Details)",
"role": "http://medixall.com/role/RelatedPartyTransactionsDetails",
"shortName": "Related Party Transactions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"lang": null,
"name": "us-gaap:RelatedPartyTransactionDueFromToRelatedParty",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "mdxl:ConvertibleDebtNetOfDiscount",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
"role": "http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "mdxl:ConvertibleDebtNetOfDiscount",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R30": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2021-04-012021-04-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DebtInstrumentPeriodicPayment",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000030 - Disclosure - Related Party Transactions (Details Narrative)",
"role": "http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative",
"shortName": "Related Party Transactions (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2021-04-012021-04-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DebtInstrumentPeriodicPayment",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R31": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:SharePrice",
"reportCount": 1,
"unique": true,
"unitRef": "USDPShares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000031 - Disclosure - Senior Convertible Debentures and Warrants (Details)",
"role": "http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"shortName": "Senior Convertible Debentures and Warrants (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2022-06-30",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:SharePrice",
"reportCount": 1,
"unique": true,
"unitRef": "USDPShares",
"xsiNil": "false"
}
},
"R32": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-03-012022-03-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:SecuritiesPurchaseAgreementDescription",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000032 - Disclosure - Senior Convertible Debentures and Warrants (Details Narrative)",
"role": "http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative",
"shortName": "Senior Convertible Debentures and Warrants (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-03-012022-03-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:SecuritiesPurchaseAgreementDescription",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R4": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
"role": "http://medixall.com/role/CondensedConsolidatedStatementsOfOperations",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "AsOf2020-12-31_custom_SeriesAVotingPreferredStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)",
"role": "http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2021-01-012021-03-31_us-gaap_CommonStockMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:StockIssuedDuringPeriodValueOther",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30_us-gaap_CommonStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsOfStockIssuanceCosts",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (Parenthetical)",
"role": "http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical",
"shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-04-012022-06-30_us-gaap_CommonStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsOfStockIssuanceCosts",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
"role": "http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": "0",
"lang": null,
"name": "us-gaap:Depreciation",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000008 - Disclosure - Organization and Nature of Operation",
"role": "http://medixall.com/role/OrganizationAndNatureOfOperation",
"shortName": "Organization and Nature of Operation",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:AssetAcquisitionDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000009 - Disclosure - Asset Acquisition",
"role": "http://medixall.com/role/AssetAcquisition",
"shortName": "Asset Acquisition",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "mdxl_10q.htm",
"contextRef": "From2022-01-01to2022-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "mdxl:AssetAcquisitionDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 18,
"tag": {
"dei_AmendmentDescription": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Description of changes contained within amended document.",
"label": "Amendment Description"
}
}
},
"localname": "AmendmentDescription",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "stringItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_AnnualInformationForm": {
"auth_ref": [
"r342"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
"label": "Annual Information Form"
}
}
},
"localname": "AnnualInformationForm",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_AuditedAnnualFinancialStatements": {
"auth_ref": [
"r342"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
"label": "Audited Annual Financial Statements"
}
}
},
"localname": "AuditedAnnualFinancialStatements",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CountryRegion": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Region code of country",
"label": "Country Region"
}
}
},
"localname": "CountryRegion",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentAccountingStandard": {
"auth_ref": [
"r341"
],
"lang": {
"en-us": {
"role": {
"documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
"label": "Document Accounting Standard"
}
}
},
"localname": "DocumentAccountingStandard",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "accountingStandardItemType"
},
"dei_DocumentAnnualReport": {
"auth_ref": [
"r339",
"r341",
"r342"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an annual report.",
"label": "Document Annual Report"
}
}
},
"localname": "DocumentAnnualReport",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.",
"label": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentPeriodStartDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
"label": "Document Period Start Date"
}
}
},
"localname": "DocumentPeriodStartDate",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r340"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentRegistrationStatement": {
"auth_ref": [
"r328"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a registration statement.",
"label": "Document Registration Statement"
}
}
},
"localname": "DocumentRegistrationStatement",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentShellCompanyEventDate": {
"auth_ref": [
"r341"
],
"lang": {
"en-us": {
"role": {
"documentation": "Date of event requiring a shell company report.",
"label": "Document Shell Company Event Date"
}
}
},
"localname": "DocumentShellCompanyEventDate",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentShellCompanyReport": {
"auth_ref": [
"r341"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
"label": "Document Shell Company Report"
}
}
},
"localname": "DocumentShellCompanyReport",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r343"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "submissionTypeItemType"
},
"dei_DocumentsIncorporatedByReferenceTextBlock": {
"auth_ref": [
"r331"
],
"lang": {
"en-us": {
"role": {
"documentation": "Documents incorporated by reference.",
"label": "Documents Incorporated by Reference [Text Block]"
}
}
},
"localname": "DocumentsIncorporatedByReferenceTextBlock",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "textBlockItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine2": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 2 such as Street or Suite number",
"label": "Entity Address, Address Line Two"
}
}
},
"localname": "EntityAddressAddressLine2",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine3": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 3 such as an Office Park",
"label": "Entity Address, Address Line Three"
}
}
},
"localname": "EntityAddressAddressLine3",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCountry": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "ISO 3166-1 alpha-2 country code.",
"label": "Entity Address, Country"
}
}
},
"localname": "EntityAddressCountry",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "countryCodeItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityBankruptcyProceedingsReportingCurrent": {
"auth_ref": [
"r334"
],
"lang": {
"en-us": {
"role": {
"documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
"label": "Entity Bankruptcy Proceedings, Reporting Current"
}
}
},
"localname": "EntityBankruptcyProceedingsReportingCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityDomain": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
}
}
},
"localname": "EntityDomain",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityExTransitionPeriod": {
"auth_ref": [
"r348"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
"label": "Elected Not To Use the Extended Transition Period"
}
}
},
"localname": "EntityExTransitionPeriod",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r345"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityPrimarySicNumber": {
"auth_ref": [
"r342"
],
"lang": {
"en-us": {
"role": {
"documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
"label": "Entity Primary SIC Number"
}
}
},
"localname": "EntityPrimarySicNumber",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "sicNumberItemType"
},
"dei_EntityPublicFloat": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
"label": "Entity Public Float"
}
}
},
"localname": "EntityPublicFloat",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "monetaryItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r330"
],
"lang": {
"en-us": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "employerIdItemType"
},
"dei_EntityVoluntaryFilers": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
"label": "Entity Voluntary Filers"
}
}
},
"localname": "EntityVoluntaryFilers",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityWellKnownSeasonedIssuer": {
"auth_ref": [
"r346"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
"label": "Entity Well-known Seasoned Issuer"
}
}
},
"localname": "EntityWellKnownSeasonedIssuer",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_Extension": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Extension number for local phone number.",
"label": "Extension"
}
}
},
"localname": "Extension",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_LegalEntityAxis": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The set of legal entities associated with a report.",
"label": "Legal Entity [Axis]"
}
}
},
"localname": "LegalEntityAxis",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_NoTradingSymbolFlag": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a security having no trading symbol.",
"label": "No Trading Symbol Flag"
}
}
},
"localname": "NoTradingSymbolFlag",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "trueItemType"
},
"dei_OtherReportingStandardItemNumber": {
"auth_ref": [
"r341"
],
"lang": {
"en-us": {
"role": {
"documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
"label": "Other Reporting Standard Item Number"
}
}
},
"localname": "OtherReportingStandardItemNumber",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "otherReportingStandardItemNumberItemType"
},
"dei_PreCommencementIssuerTenderOffer": {
"auth_ref": [
"r335"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
"label": "Pre-commencement Issuer Tender Offer"
}
}
},
"localname": "PreCommencementIssuerTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_PreCommencementTenderOffer": {
"auth_ref": [
"r336"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
"label": "Pre-commencement Tender Offer"
}
}
},
"localname": "PreCommencementTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r329"
],
"lang": {
"en-us": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "securityTitleItemType"
},
"dei_Security12gTitle": {
"auth_ref": [
"r333"
],
"lang": {
"en-us": {
"role": {
"documentation": "Title of a 12(g) registered security.",
"label": "Title of 12(g) Security"
}
}
},
"localname": "Security12gTitle",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r332"
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_SecurityReportingObligation": {
"auth_ref": [
"r337"
],
"lang": {
"en-us": {
"role": {
"documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
"label": "Security Reporting Obligation"
}
}
},
"localname": "SecurityReportingObligation",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "securityReportingObligationItemType"
},
"dei_SolicitingMaterial": {
"auth_ref": [
"r338"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
"label": "Soliciting Material"
}
}
},
"localname": "SolicitingMaterial",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "tradingSymbolItemType"
},
"dei_WrittenCommunications": {
"auth_ref": [
"r347"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
"label": "Written Communications"
}
}
},
"localname": "WrittenCommunications",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"presentation": [
"http://medixall.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"mdxl_AdditionalSharesIssued": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Additional shares issued"
}
}
},
"localname": "AdditionalSharesIssued",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"mdxl_AmortizationOfDebentureDiscounts": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "AmortizationOfDebentureDiscounts",
"negatedLabel": "Amortization of debenture discounts"
}
}
},
"localname": "AmortizationOfDebentureDiscounts",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_AmortizationOfRightofuseOperatingLeaseAsset": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Amortization of right-of-use operating lease asset"
}
}
},
"localname": "AmortizationOfRightofuseOperatingLeaseAsset",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_AmortizationOfRighttouseIntellectualProperty": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Amortization of right-to-use intellectual property"
}
}
},
"localname": "AmortizationOfRighttouseIntellectualProperty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_AssetAcquisitionDisclosureTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "AssetAcquisitionDisclosureTextBlock",
"verboseLabel": "Asset Acquisition"
}
}
},
"localname": "AssetAcquisitionDisclosureTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/AssetAcquisition"
],
"xbrltype": "textBlockItemType"
},
"mdxl_BasicAndDilutedLps": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Basic and diluted LPS"
}
}
},
"localname": "BasicAndDilutedLps",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "sharesItemType"
},
"mdxl_CommonStockIssuedInExchangeForRighttouseIntellectualProperty": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "Common stock issued in exchange for right-to-use intellectual property (Unaudited)"
}
}
},
"localname": "CommonStockIssuedInExchangeForRighttouseIntellectualProperty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"mdxl_CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Common stock issued in exchange for right-to-use intellectual property, Shares"
}
}
},
"localname": "CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"mdxl_ConvertibleDebtNetOfDiscount": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "Net of discount"
}
}
},
"localname": "ConvertibleDebtNetOfDiscount",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "monetaryItemType"
},
"mdxl_ConvertiblePreferredStockTotalSharesIssuedUponConversion": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued for total shares of convertible preferred stock that is converted.",
"label": "Number of common stock issuable for total shares of convertible preferred stock"
}
}
},
"localname": "ConvertiblePreferredStockTotalSharesIssuedUponConversion",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"mdxl_DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Decrease in note payable resulting from gain on forgiveness of note payable"
}
}
},
"localname": "DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_DenominatorAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Denominator:"
}
}
},
"localname": "DenominatorAbstract",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "stringItemType"
},
"mdxl_DisclosureAssetAcquisitionAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Asset Acquisition"
}
}
},
"localname": "DisclosureAssetAcquisitionAbstract",
"nsuri": "http://medixall.com/20220630",
"xbrltype": "stringItemType"
},
"mdxl_DisclosureSeniorConvertibleDebenturesAndWarrantsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Senior Convertible Debentures And Warrants"
}
}
},
"localname": "DisclosureSeniorConvertibleDebenturesAndWarrantsAbstract",
"nsuri": "http://medixall.com/20220630",
"xbrltype": "stringItemType"
},
"mdxl_DiscountIssuedWithConvertibleDebentures": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Discount issued with Convertible Debentures"
}
}
},
"localname": "DiscountIssuedWithConvertibleDebentures",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_EarningsPerSharesBasicAndDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Basic and Diluted LPS Computation"
}
}
},
"localname": "EarningsPerSharesBasicAndDilutedAbstract",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "stringItemType"
},
"mdxl_FairValueOfWarrants": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Fair value of warrants"
}
}
},
"localname": "FairValueOfWarrants",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"mdxl_FairValueOfWarrantsIssuedWithConvertibleDebentures": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "Fair Value of warrants Issued with Convertible Debentures (Unaudited)"
}
}
},
"localname": "FairValueOfWarrantsIssuedWithConvertibleDebentures",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"mdxl_GainFromForgivenessOfNotePayable": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "GainFromForgivenessOfNotePayable",
"negatedLabel": "Gain from forgiveness of note payable"
}
}
},
"localname": "GainFromForgivenessOfNotePayable",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_IncreaseDecreaseInPrepaidExpensesRelatedParty": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Prepaid expenses- related party"
}
}
},
"localname": "IncreaseDecreaseInPrepaidExpensesRelatedParty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_IntellectualPropertyValue": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Intellectual property value"
}
}
},
"localname": "IntellectualPropertyValue",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"mdxl_IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Issuance of Common Stock in exchange for the Right-of-Use Intellectual Property"
}
}
},
"localname": "IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_LossAvailableToCommonStockholders": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "Loss available to common stockholders"
}
}
},
"localname": "LossAvailableToCommonStockholders",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "monetaryItemType"
},
"mdxl_ManagementFeeRelatedParty": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 3.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Management fees - related party"
}
}
},
"localname": "ManagementFeeRelatedParty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"mdxl_MediXallGroupIncMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Medi Xall Group Inc [Member]"
}
}
},
"localname": "MediXallGroupIncMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"mdxl_NumeratorAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Numerator:"
}
}
},
"localname": "NumeratorAbstract",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "stringItemType"
},
"mdxl_ProceedsReceivedFromSaleOfPreferredStock": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "Proceeds received from sale of Preferred Stock (Unaudited)"
}
}
},
"localname": "ProceedsReceivedFromSaleOfPreferredStock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"mdxl_ProceedsReceivedFromSaleOfPreferredStockShares": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Proceeds received from sale of Preferred Stock, Shares"
}
}
},
"localname": "ProceedsReceivedFromSaleOfPreferredStockShares",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"mdxl_ProfessionalFeesRelatedParty": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"label": "Professional fees - related party"
}
}
},
"localname": "ProfessionalFeesRelatedParty",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"mdxl_R3AccountingLLCMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Represents details pertaining to R3Accounting, LLC.",
"label": "R3 Accounting LLC [Member]"
}
}
},
"localname": "R3AccountingLLCMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails",
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"mdxl_RightsToUseIntellectualPropertyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Rights-to-use Intellectual Property"
}
}
},
"localname": "RightsToUseIntellectualPropertyPolicyTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"mdxl_ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of amortization expense for right-to-use intellectual property"
}
}
},
"localname": "ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyTables"
],
"xbrltype": "textBlockItemType"
},
"mdxl_ScheduleOfRightToUseIntellectualPropertyTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Right-to-use Intellectual Property"
}
}
},
"localname": "ScheduleOfRightToUseIntellectualPropertyTableTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyTables"
],
"xbrltype": "textBlockItemType"
},
"mdxl_SecuritiesPurchaseAgreementDescription": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Securities purchase agreement, description"
}
}
},
"localname": "SecuritiesPurchaseAgreementDescription",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"mdxl_SeniorConvertibleDebenturesAndWarrantsMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Senior Convertible Debentures and Warrants [Member]"
}
}
},
"localname": "SeniorConvertibleDebenturesAndWarrantsMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"mdxl_SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock",
"verboseLabel": "Senior Convertible Debentures and Warrants"
}
}
},
"localname": "SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"mdxl_SeniorConvertibleDebenturesAndWarrantsTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Senior Convertible Debentures and Warrants"
}
}
},
"localname": "SeniorConvertibleDebenturesAndWarrantsTextBlock",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrants"
],
"xbrltype": "textBlockItemType"
},
"mdxl_SeriesAVotingPreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Series A Voting Preferred Stock [Member]"
}
}
},
"localname": "SeriesAVotingPreferredStockMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"mdxl_SeriesBVotingPreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Series B Voting Preferred Stock [Member]"
}
}
},
"localname": "SeriesBVotingPreferredStockMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"mdxl_TBGHoldingsCorpMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Tbg holdings corp member.",
"label": "T B G Holdings Corp [Member]"
}
}
},
"localname": "TBGHoldingsCorpMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "domainItemType"
},
"mdxl_TBGMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "T B G [Member]"
}
}
},
"localname": "TBGMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"mdxl_ThreeConvertibleLoanDebenturesMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Three Convertible Loan Debentures [Member]"
}
}
},
"localname": "ThreeConvertibleLoanDebenturesMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"mdxl_TurnkeyMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Turnkey [Member]"
}
}
},
"localname": "TurnkeyMember",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "domainItemType"
},
"mdxl_WebsiteAndDevelopmentCosts": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"label": "WebsiteAndDevelopmentCosts",
"negatedLabel": "Website development costs"
}
}
},
"localname": "WebsiteAndDevelopmentCosts",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"mdxl_WeightedAverageNumberOfCommonSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Weighted average number of common shares outstanding"
}
}
},
"localname": "WeightedAverageNumberOfCommonSharesOutstanding",
"nsuri": "http://medixall.com/20220630",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "sharesItemType"
},
"srt_MaximumMember": {
"auth_ref": [
"r145",
"r146",
"r147",
"r148",
"r166",
"r192",
"r208",
"r209",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r278",
"r314",
"r315",
"r325",
"r326"
],
"lang": {
"en-us": {
"role": {
"label": "Maximum [Member]"
}
}
},
"localname": "MaximumMember",
"nsuri": "http://fasb.org/srt/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_MinimumMember": {
"auth_ref": [
"r145",
"r146",
"r147",
"r148",
"r166",
"r192",
"r208",
"r209",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r278",
"r314",
"r315",
"r325",
"r326"
],
"lang": {
"en-us": {
"role": {
"label": "Minimum [Member]"
}
}
},
"localname": "MinimumMember",
"nsuri": "http://fasb.org/srt/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_RangeAxis": {
"auth_ref": [
"r144",
"r145",
"r146",
"r147",
"r148",
"r166",
"r192",
"r206",
"r208",
"r209",
"r214",
"r215",
"r216",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r278",
"r314",
"r315",
"r325",
"r326"
],
"lang": {
"en-us": {
"role": {
"label": "Statistical Measurement [Axis]"
}
}
},
"localname": "RangeAxis",
"nsuri": "http://fasb.org/srt/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"srt_RangeMember": {
"auth_ref": [
"r144",
"r145",
"r146",
"r147",
"r148",
"r166",
"r192",
"r206",
"r208",
"r209",
"r214",
"r215",
"r216",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r278",
"r314",
"r315",
"r325",
"r326"
],
"localname": "RangeMember",
"nsuri": "http://fasb.org/srt/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r23"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Accounts payable and accrued expenses"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsPayableRelatedPartiesCurrent": {
"auth_ref": [
"r22",
"r62",
"r264",
"r265"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Accounts payable and accrued expenses - related party",
"negatedLabel": "Accounts payable and accrued expenses - related party"
}
}
},
"localname": "AccountsPayableRelatedPartiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapital": {
"auth_ref": [
"r14",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
"label": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapital",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
"r65",
"r66",
"r67",
"r218",
"r219",
"r220",
"r240"
],
"lang": {
"en-us": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-in Capital [Member]"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Adjustments to reconcile net loss to net cash used in operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_AmortizationOfDebtDiscountPremium": {
"auth_ref": [
"r43",
"r50",
"r179",
"r253"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
"label": "Amortization of Debt Discount (Premium)"
}
}
},
"localname": "AmortizationOfDebtDiscountPremium",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
"auth_ref": [
"r93"
],
"lang": {
"en-us": {
"role": {
"documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
"label": "Anti-dilutive securities"
}
}
},
"localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r9",
"r60",
"r112",
"r115",
"r121",
"r128",
"r150",
"r151",
"r152",
"r154",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r234",
"r237",
"r244",
"r268",
"r270",
"r295",
"r306"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r5",
"r21",
"r60",
"r128",
"r150",
"r151",
"r152",
"r154",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r234",
"r237",
"r244",
"r268",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CURRENT ASSETS:"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Basis of Presentation"
}
}
},
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CapitalizedComputerSoftwareNet": {
"auth_ref": [
"r327"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
"label": "Capitalized Computer Software, Net",
"verboseLabel": "Website and development costs"
}
}
},
"localname": "CapitalizedComputerSoftwareNet",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Cash": {
"auth_ref": [
"r7",
"r270",
"r321",
"r322"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash"
}
}
},
"localname": "Cash",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"auth_ref": [
"r47",
"r52",
"r53"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
"periodEndLabel": "Cash at end of period",
"periodStartLabel": "Cash at beginning of period"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
"auth_ref": [
"r47",
"r245"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
"totalLabel": "Net increase (decrease) in cash"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Supplemental disclosures of non-cash information"
}
}
},
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfStockDomain": {
"auth_ref": [
"r11",
"r12",
"r13",
"r58",
"r60",
"r81",
"r82",
"r87",
"r90",
"r92",
"r98",
"r99",
"r100",
"r128",
"r150",
"r155",
"r156",
"r157",
"r161",
"r162",
"r190",
"r191",
"r194",
"r195",
"r197",
"r244",
"r344"
],
"lang": {
"en-us": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
}
}
},
"localname": "ClassOfStockDomain",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
"auth_ref": [
"r198"
],
"lang": {
"en-us": {
"role": {
"documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
"label": "Exercise price"
}
}
},
"localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ClassOfWarrantOrRightOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of warrants or rights outstanding.",
"label": "Issuance of warrants"
}
}
},
"localname": "ClassOfWarrantOrRightOutstanding",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockDividendsShares": {
"auth_ref": [
"r197"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.",
"label": "Common stock issued in satisfaction of preferred stock dividend"
}
}
},
"localname": "CommonStockDividendsShares",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
"r65",
"r66",
"r240"
],
"lang": {
"en-us": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, Par value (in dollars per share)"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, shares authorized"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common Stock, shares issued"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r13",
"r197"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, shares outstanding"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r13",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common Stock, $0.001 par value 750,000,000 shares authorized; 117,235,039 and 110,864,595 shares issued and outstanding"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConcentrationRiskCreditRisk": {
"auth_ref": [
"r103",
"r305"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for credit risk.",
"label": "Risks and Uncertainties"
}
}
},
"localname": "ConcentrationRiskCreditRisk",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ConsolidationPolicyTextBlock": {
"auth_ref": [
"r55",
"r236"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
"label": "Principles of Consolidation"
}
}
},
"localname": "ConsolidationPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ConvertibleDebtCurrent": {
"auth_ref": [
"r10"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
"label": "Senior Convertible Debentures, net of discount of 77,021"
}
}
},
"localname": "ConvertibleDebtCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentConvertibleConversionPrice1": {
"auth_ref": [
"r165",
"r181"
],
"lang": {
"en-us": {
"role": {
"documentation": "The price per share of the conversion feature embedded in the debt instrument.",
"label": "Price per share upon conversion of debentures"
}
}
},
"localname": "DebtInstrumentConvertibleConversionPrice1",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
"auth_ref": [
"r27",
"r182",
"r254",
"r255"
],
"lang": {
"en-us": {
"role": {
"documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
"label": "Interest rate"
}
}
},
"localname": "DebtInstrumentInterestRateEffectivePercentage",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Instrument [Line Items]"
}
}
},
"localname": "DebtInstrumentLineItems",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentMaturityDate": {
"auth_ref": [
"r28",
"r166",
"r243"
],
"lang": {
"en-us": {
"role": {
"documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
"label": "Maturity date"
}
}
},
"localname": "DebtInstrumentMaturityDate",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "dateItemType"
},
"us-gaap_DebtInstrumentPeriodicPayment": {
"auth_ref": [
"r29",
"r303"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of the required periodic payments including both interest and principal payments.",
"label": "Debt Instrument, Periodic Payment"
}
}
},
"localname": "DebtInstrumentPeriodicPayment",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentTable": {
"auth_ref": [
"r29",
"r59",
"r63",
"r163",
"r164",
"r165",
"r166",
"r167",
"r168",
"r169",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r179",
"r180",
"r183",
"r184",
"r185",
"r186",
"r198",
"r201",
"r202",
"r203",
"r253",
"r254",
"r255",
"r256",
"r304"
],
"lang": {
"en-us": {
"role": {
"documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Schedule of Long-Term Debt Instruments [Table]"
}
}
},
"localname": "DebtInstrumentTable",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_Depreciation": {
"auth_ref": [
"r50",
"r140"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
"label": "Depreciation"
}
}
},
"localname": "Depreciation",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DividendsPayableCurrent": {
"auth_ref": [
"r25"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Cummulative unpaid dividends"
}
}
},
"localname": "DividendsPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DividendsPreferredStock": {
"auth_ref": [
"r204",
"r302"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
"label": "Less preferred stock dividends"
}
}
},
"localname": "DividendsPreferredStock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DividendsPreferredStockStock": {
"auth_ref": [
"r204",
"r302"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
"label": "Series B Preferred Stock Dividends"
}
}
},
"localname": "DividendsPreferredStockStock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EarningsPerShareAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Net loss per common stock"
}
}
},
"localname": "EarningsPerShareAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r40",
"r70",
"r71",
"r72",
"r73",
"r74",
"r78",
"r81",
"r90",
"r91",
"r92",
"r95",
"r96",
"r241",
"r242",
"r299",
"r311"
],
"lang": {
"en-us": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Basic"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r40",
"r70",
"r71",
"r72",
"r73",
"r74",
"r81",
"r90",
"r91",
"r92",
"r95",
"r96",
"r241",
"r242",
"r299",
"r311"
],
"lang": {
"en-us": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Diluted"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerSharePolicyTextBlock": {
"auth_ref": [
"r93",
"r94"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
"label": "Loss Per Share"
}
}
},
"localname": "EarningsPerSharePolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Equity [Abstract]"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r0",
"r34",
"r35",
"r36",
"r65",
"r66",
"r67",
"r69",
"r75",
"r77",
"r97",
"r129",
"r197",
"r204",
"r218",
"r219",
"r220",
"r230",
"r231",
"r240",
"r246",
"r247",
"r248",
"r249",
"r250",
"r251",
"r259",
"r316",
"r317",
"r318"
],
"lang": {
"en-us": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "domainItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
"auth_ref": [
"r8",
"r136"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Accumulated Amortization",
"negatedLabel": "Accumulated amortization"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 1.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "2022 (six months)"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 6.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Thereafter"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 5.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "2026"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 4.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "2025"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 3.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "2024"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": 2.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "2023"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsGross": {
"auth_ref": [
"r136",
"r281"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Gross"
}
}
},
"localname": "FiniteLivedIntangibleAssetsGross",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsNet": {
"auth_ref": [
"r136",
"r280"
],
"calculation": {
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Net carrying amount",
"totalLabel": "Total"
}
}
},
"localname": "FiniteLivedIntangibleAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails",
"http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Goodwill and Intangible Assets Disclosure [Abstract]"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
"auth_ref": [
"r132",
"r134"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
"label": "Website and Development Costs"
}
}
},
"localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
"auth_ref": [
"r50",
"r139",
"r142"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
"label": "Impairment of long-lived assets"
}
}
},
"localname": "ImpairmentOfLongLivedAssetsHeldForUse",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
"auth_ref": [
"r138",
"r143"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
"label": "Recoverability of Long-Lived Assets"
}
}
},
"localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
"auth_ref": [
"r38",
"r112",
"r114",
"r117",
"r120",
"r122",
"r294",
"r297",
"r300",
"r312"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
"label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
"totalLabel": "Loss before income taxes"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r61",
"r76",
"r77",
"r111",
"r225",
"r232",
"r233",
"r313"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income taxes"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxPolicyTextBlock": {
"auth_ref": [
"r33",
"r223",
"r224",
"r226",
"r227",
"r228",
"r229"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
"label": "Income Taxes"
}
}
},
"localname": "IncomeTaxPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r49"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"verboseLabel": "Accounts payable and accrued expenses"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": {
"auth_ref": [
"r49"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
"label": "Increase (Decrease) in Accounts Payable, Related Parties",
"verboseLabel": "Accounts payable and accrued expenses - related party"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableRelatedParties",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Changes in operating assets and liabilities:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInOperatingLiabilities": {
"auth_ref": [
"r49"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
"label": "Increase (Decrease) in Operating Liabilities",
"verboseLabel": "Operating lease liability"
}
}
},
"localname": "IncreaseDecreaseInOperatingLiabilities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
"auth_ref": [
"r49"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) in current assets classified as other.",
"label": "Increase (Decrease) in Other Current Assets",
"negatedLabel": "Other assets"
}
}
},
"localname": "IncreaseDecreaseInOtherCurrentAssets",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IntangibleAssetsDisclosureTextBlock": {
"auth_ref": [
"r137"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for all or part of the information related to intangible assets.",
"label": "Right-to-use Intellectual Property"
}
}
},
"localname": "IntangibleAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/Right-to-useIntellectualProperty"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IntangibleAssetsNetExcludingGoodwill": {
"auth_ref": [
"r133",
"r135"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
"label": "Website and development costs"
}
}
},
"localname": "IntangibleAssetsNetExcludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
"auth_ref": [
"r50"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
"label": "Common stock issued as compensation for services"
}
}
},
"localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LaborAndRelatedExpense": {
"auth_ref": [
"r41"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 4.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
"label": "Personnel related expenses"
}
}
},
"localname": "LaborAndRelatedExpense",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r24",
"r60",
"r116",
"r128",
"r150",
"r151",
"r152",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r235",
"r237",
"r238",
"r244",
"r268",
"r269"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r18",
"r60",
"r128",
"r244",
"r270",
"r296",
"r308"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total liabilities and stockholders' deficit"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "LIABILITIES AND STOCKHOLDERS' DEFICIT"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r6",
"r26",
"r60",
"r128",
"r150",
"r151",
"r152",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r235",
"r237",
"r238",
"r244",
"r268",
"r269",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total current liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CURRENT LIABILITIES:"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LongtermDebtTypeAxis": {
"auth_ref": [
"r29"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by type of long-term debt.",
"label": "Long-Term Debt, Type [Axis]"
}
}
},
"localname": "LongtermDebtTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_LongtermDebtTypeDomain": {
"auth_ref": [
"r29",
"r149"
],
"lang": {
"en-us": {
"role": {
"documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
}
}
},
"localname": "LongtermDebtTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_ManagementFeeExpense": {
"auth_ref": [
"r264"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).",
"label": "Management fee - related party"
}
}
},
"localname": "ManagementFeeExpense",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MarketingExpense": {
"auth_ref": [
"r42"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
"label": "Marketing and Consulting expenses"
}
}
},
"localname": "MarketingExpense",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r47"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r47"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash used in investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r47",
"r48",
"r51"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash used in operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r1",
"r31",
"r32",
"r36",
"r39",
"r51",
"r60",
"r68",
"r70",
"r71",
"r72",
"r73",
"r76",
"r77",
"r88",
"r112",
"r114",
"r117",
"r120",
"r122",
"r128",
"r150",
"r151",
"r152",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r242",
"r244",
"r298",
"r310"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net loss (Unaudited)",
"totalLabel": "Net loss",
"verboseLabel": "Net loss"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows",
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
"auth_ref": [
"r70",
"r71",
"r72",
"r73",
"r78",
"r79",
"r89",
"r92",
"r112",
"r114",
"r117",
"r120",
"r122"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
"label": "Net Income (Loss) Available to Common Stockholders, Basic",
"totalLabel": "Net loss to common stockholders"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
"auth_ref": [
"r80",
"r83",
"r84",
"r85",
"r86",
"r89",
"r92"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
"label": "Net loss"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "Recent Accounting Pronouncements"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OperatingExpenses": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
"label": "Operating Expenses [Default Label]",
"totalLabel": "Total Operating Expenses"
}
}
},
"localname": "OperatingExpenses",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingExpensesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Operating Expenses"
}
}
},
"localname": "OperatingExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingLeaseLiabilityCurrent": {
"auth_ref": [
"r258"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
"label": "Operating lease liability"
}
}
},
"localname": "OperatingLeaseLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiabilityNoncurrent": {
"auth_ref": [
"r258"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
"label": "Operating lease liability, net of current portion"
}
}
},
"localname": "OperatingLeaseLiabilityNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseRightOfUseAsset": {
"auth_ref": [
"r257"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's right to use underlying asset under operating lease.",
"label": "Right-of-use-operating lease asset"
}
}
},
"localname": "OperatingLeaseRightOfUseAsset",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
"auth_ref": [
"r3",
"r239"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
"label": "Organization and Nature of Operation"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/OrganizationAndNatureOfOperation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherAssetsCurrent": {
"auth_ref": [
"r20",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of current assets classified as other.",
"label": "Other assets"
}
}
},
"localname": "OtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherIntangibleAssetsNet": {
"auth_ref": [
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
"label": "Rights-to-use intellectual property"
}
}
},
"localname": "OtherIntangibleAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherPrepaidExpenseCurrent": {
"auth_ref": [
"r19",
"r131"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Other Prepaid Expense, Current",
"verboseLabel": "Prepaid expenses- related party"
}
}
},
"localname": "OtherPrepaidExpenseCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
"auth_ref": [
"r42"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 5.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of selling, general and administrative expense classified as other.",
"label": "Other selling, general and administrative"
}
}
},
"localname": "OtherSellingGeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsOfStockIssuanceCosts": {
"auth_ref": [
"r46"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
"label": "Offering costs"
}
}
},
"localname": "PaymentsOfStockIssuanceCosts",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PreferredStockDividendRatePerDollarAmount": {
"auth_ref": [
"r191"
],
"lang": {
"en-us": {
"role": {
"documentation": "The amount per share used to calculated dividend payments on preferred stock.",
"label": "Stock dividend"
}
}
},
"localname": "PreferredStockDividendRatePerDollarAmount",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockDividendRatePercentage": {
"auth_ref": [
"r191"
],
"lang": {
"en-us": {
"role": {
"documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
"label": "Dividend rate"
}
}
},
"localname": "PreferredStockDividendRatePercentage",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r12",
"r190"
],
"lang": {
"en-us": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Convertible Preferred stock, par value (in dollars per share)",
"verboseLabel": "Convertible Preferred stock, par value"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r12"
],
"lang": {
"en-us": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Convertible Preferred stock, shares authorized"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r12",
"r190"
],
"lang": {
"en-us": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Convertible Preferred stock, shares issued"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r12"
],
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Convertible Preferred stock, shares outstanding"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockTextBlock": {
"auth_ref": [
"r205"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
"label": "Preferred Stock"
}
}
},
"localname": "PreferredStockTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStock"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r12",
"r270"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock, Value, Issued"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseCurrent": {
"auth_ref": [
"r4",
"r19",
"r130",
"r131"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Prepaid expenses - related party",
"verboseLabel": "Prepaid expense"
}
}
},
"localname": "PrepaidExpenseCurrent",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromConvertibleDebt": {
"auth_ref": [
"r45"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
"label": "Proceeds from issuance of convertible debentures",
"verboseLabel": "Proceeds from convertible debentures"
}
}
},
"localname": "ProceedsFromConvertibleDebt",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows",
"http://medixall.com/role/GoingConcernDetailsNarrative",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfCommonStock": {
"auth_ref": [
"r44"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash inflow from the additional capital contribution to the entity.",
"label": "Proceeds from the sale of common stock, net of offering costs"
}
}
},
"localname": "ProceedsFromIssuanceOfCommonStock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
"auth_ref": [
"r44"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
"label": "Proceeds from the sale of preferred stock"
}
}
},
"localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProfessionalFees": {
"auth_ref": [
"r323",
"r324"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
"label": "Professional fees"
}
}
},
"localname": "ProfessionalFees",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentNet": {
"auth_ref": [
"r141",
"r270",
"r301",
"r309"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Furniture and equipment, net"
}
}
},
"localname": "PropertyPlantAndEquipmentNet",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
"auth_ref": [
"r126"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
"label": "Allowance for Uncollectible Accounts Receivable"
}
}
},
"localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RelatedPartyDomain": {
"auth_ref": [
"r207",
"r262",
"r263"
],
"lang": {
"en-us": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"localname": "RelatedPartyDomain",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails",
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionDueFromToRelatedParty": {
"auth_ref": [
"r62",
"r153",
"r155",
"r156",
"r160",
"r161",
"r162",
"r263"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
"label": "Related Party Transaction, Due from (to) Related Party",
"negatedLabel": "Due from (to) related party"
}
}
},
"localname": "RelatedPartyTransactionDueFromToRelatedParty",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
"auth_ref": [
"r262"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
"label": "Fee for consulting and administrative services"
}
}
},
"localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyTransactionLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Related Party Transaction [Line Items]"
}
}
},
"localname": "RelatedPartyTransactionLineItems",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails",
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"localname": "RelatedPartyTransactionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"auth_ref": [
"r207",
"r262",
"r265",
"r282",
"r283",
"r284",
"r285",
"r286",
"r287",
"r288",
"r289",
"r290",
"r291",
"r292",
"r293"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Axis]"
}
}
},
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails",
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"auth_ref": [
"r260",
"r261",
"r263",
"r266",
"r267"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Related Party Transactions"
}
}
},
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r15",
"r204",
"r270",
"r307",
"r319",
"r320"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated deficit",
"negatedLabel": "Retained Earnings (Accumulated Deficit)"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
"r0",
"r65",
"r66",
"r67",
"r69",
"r75",
"r77",
"r129",
"r218",
"r219",
"r220",
"r230",
"r231",
"r240",
"r316",
"r318"
],
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueRecognitionPolicyTextBlock": {
"auth_ref": [
"r56",
"r57"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
"label": "Revenue Recognition"
}
}
},
"localname": "RevenueRecognitionPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Revenues": {
"auth_ref": [
"r37",
"r60",
"r109",
"r110",
"r113",
"r118",
"r119",
"r123",
"r124",
"r125",
"r128",
"r150",
"r151",
"r152",
"r155",
"r156",
"r157",
"r158",
"r159",
"r161",
"r162",
"r244",
"r300"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
"label": "Revenue"
}
}
},
"localname": "Revenues",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
"label": "Schedule of prepaid expenses (accounts payable and accrued expenses) to related parties"
}
}
},
"localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
"auth_ref": [
"r93"
],
"lang": {
"en-us": {
"role": {
"documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
"label": "Schedule of potentially dilutive securities not included in the calculation of diluted net loss per share"
}
}
},
"localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
"auth_ref": [
"r92"
],
"lang": {
"en-us": {
"role": {
"documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
"label": "Schedule of computation of basic and diluted net loss per share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"auth_ref": [
"r264",
"r265"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Schedule of Related Party Transactions, by Related Party [Table]"
}
}
},
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/RelatedPartyTransactionsDetails",
"http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
"auth_ref": [
"r212"
],
"lang": {
"en-us": {
"role": {
"documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
"label": "Schedule of assumptions"
}
}
},
"localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r11",
"r12",
"r13",
"r58",
"r98",
"r99",
"r187",
"r188",
"r189",
"r190",
"r191",
"r192",
"r193",
"r194",
"r195",
"r196",
"r197",
"r198",
"r199",
"r200",
"r201",
"r202",
"r203",
"r204"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/PreferredStockDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_SeriesAPreferredStockMember": {
"auth_ref": [
"r11",
"r12",
"r197"
],
"lang": {
"en-us": {
"role": {
"documentation": "Series A preferred stock.",
"label": "Series A Preferred Stock [Member]"
}
}
},
"localname": "SeriesAPreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SeriesBPreferredStockMember": {
"auth_ref": [
"r11",
"r12",
"r197"
],
"lang": {
"en-us": {
"role": {
"documentation": "Series B preferred stock.",
"label": "Series B Preferred Stock [Member]"
}
}
},
"localname": "SeriesBPreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
"auth_ref": [
"r215"
],
"lang": {
"en-us": {
"role": {
"documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
"auth_ref": [
"r214"
],
"lang": {
"en-us": {
"role": {
"documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
"auth_ref": [
"r216"
],
"lang": {
"en-us": {
"role": {
"documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
"auth_ref": [
"r210",
"r211",
"r212",
"r213",
"r214",
"r217",
"r221",
"r222"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
"label": "Share-Based Payment Arrangements"
}
}
},
"localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SharePrice": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Price of a single share of a number of saleable stocks of a company.",
"label": "Stock price"
}
}
},
"localname": "SharePrice",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
"auth_ref": [
"r213"
],
"lang": {
"en-us": {
"role": {
"documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term"
}
}
},
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_SharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
"label": "Shares, Outstanding",
"periodEndLabel": "Ending balance, Shares",
"periodStartLabel": "Beginning balance, Shares"
}
}
},
"localname": "SharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r54",
"r64"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
"label": "Summary of Significant Accounting Policies"
}
}
},
"localname": "SignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_StatementClassOfStockAxis": {
"auth_ref": [
"r11",
"r12",
"r13",
"r58",
"r60",
"r81",
"r82",
"r87",
"r90",
"r92",
"r98",
"r99",
"r100",
"r128",
"r150",
"r155",
"r156",
"r157",
"r161",
"r162",
"r190",
"r191",
"r194",
"r195",
"r197",
"r244",
"r344"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by the different classes of stock of the entity.",
"label": "Class of Stock [Axis]"
}
}
},
"localname": "StatementClassOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/PreferredStockDetailsNarrative",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r0",
"r30",
"r34",
"r35",
"r36",
"r65",
"r66",
"r67",
"r69",
"r75",
"r77",
"r97",
"r129",
"r197",
"r204",
"r218",
"r219",
"r220",
"r230",
"r231",
"r240",
"r246",
"r247",
"r248",
"r249",
"r250",
"r251",
"r259",
"r316",
"r317",
"r318"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
"r65",
"r66",
"r67",
"r97",
"r279"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative",
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical",
"http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails",
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
"label": "Common stock issued for services, Shares"
}
}
},
"localname": "StockIssuedDuringPeriodSharesIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
"auth_ref": [
"r12",
"r13",
"r197",
"r204"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of new stock issued during the period.",
"label": "Number of shares issued"
}
}
},
"localname": "StockIssuedDuringPeriodSharesNewIssues",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/AssetAcquisitionDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesOther": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of stock issued attributable to transactions classified as other.",
"label": "Proceeds received pursuant to Private Placement Memorandum, net of $0 offering costs, Shares"
}
}
},
"localname": "StockIssuedDuringPeriodSharesOther",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
"label": "Common stock issued for services (Unaudited)"
}
}
},
"localname": "StockIssuedDuringPeriodValueIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockIssuedDuringPeriodValueOther": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value of shares of stock issued attributable to transactions classified as other.",
"label": "Proceeds received pursuant to Private Placement Memorandum, net of $0 offering costs (Unaudited)"
}
}
},
"localname": "StockIssuedDuringPeriodValueOther",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r13",
"r16",
"r17",
"r60",
"r127",
"r128",
"r244",
"r270"
],
"calculation": {
"http://medixall.com/role/CondensedConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"periodEndLabel": "Ending balance, value",
"periodStartLabel": "Beginning balance, value",
"totalLabel": "Total stockholders' deficit"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets",
"http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "STOCKHOLDERS' DEFICIT:"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
"label": "Subsequent Event [Line Items]"
}
}
},
"localname": "SubsequentEventLineItems",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventMember": {
"auth_ref": [
"r252",
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event [Member]"
}
}
},
"localname": "SubsequentEventMember",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventTable": {
"auth_ref": [
"r252",
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
"label": "Subsequent Event [Table]"
}
}
},
"localname": "SubsequentEventTable",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeAxis": {
"auth_ref": [
"r252",
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Axis]"
}
}
},
"localname": "SubsequentEventTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeDomain": {
"auth_ref": [
"r252",
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
}
}
},
"localname": "SubsequentEventTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for reporting subsequent events.",
"label": "Subsequent Events"
}
}
},
"localname": "SubsequentEventsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
"auth_ref": [
"r2"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
"label": "Going Concern"
}
}
},
"localname": "SubstantialDoubtAboutGoingConcernTextBlock",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/GoingConcern"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r101",
"r102",
"r104",
"r105",
"r106",
"r107",
"r108"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r80",
"r92"
],
"lang": {
"en-us": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted Average Number of Shares Outstanding, Diluted",
"verboseLabel": "Diluted"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Weighted average number of common stock outstanding during the periods"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r78",
"r92"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted Average Number of Shares Outstanding, Basic",
"verboseLabel": "Basic"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2022",
"presentation": [
"http://medixall.com/role/CondensedConsolidatedStatementsOfOperations"
],
"xbrltype": "sharesItemType"
}
},
"unitCount": 4
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "105",
"URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(19))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "272",
"URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(27)(b))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "310",
"URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "323",
"URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "340",
"URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "340",
"URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "350",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "((a)(1),(b))",
"Topic": "350",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r137": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "30",
"Topic": "350",
"URI": "https://asc.fasb.org/subtopic&trid=2144471"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.CC)",
"Topic": "360",
"URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "410",
"URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "450",
"URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "450",
"URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "20",
"Subparagraph": "(SAB Topic 5.Y.Q2)",
"Topic": "450",
"URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "20",
"Subparagraph": "(SAB Topic 5.Y.Q4)",
"Topic": "450",
"URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(5))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(5))",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(f)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(h)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "1D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "1D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "1D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "1E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "1E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "1E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "1F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "1F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "1F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(1)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "1F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "1I",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "69B",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "69C",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "69E",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "69F",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(7))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
},
"r2": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "40",
"Topic": "205",
"URI": "https://asc.fasb.org/subtopic&trid=51888271"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(8))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r205": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "https://asc.fasb.org/topic&trid=2208762"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(i)",
"Topic": "715",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(d)",
"Topic": "715",
"URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "80",
"Topic": "715",
"URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(9))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(i)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(ii)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(iii)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(iv)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(v)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 14.D.2.Q6)",
"Topic": "718",
"URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
},
"r222": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "718",
"URI": "https://asc.fasb.org/topic&trid=2228938"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
},
"r224": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
},
"r227": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(3)",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
},
"r233": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "810",
"URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "810",
"URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
},
"r237": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "810",
"URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "810",
"URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r239": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "https://asc.fasb.org/topic&trid=2197479"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)(3)",
"Topic": "815",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)(4)",
"Topic": "815",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)",
"Topic": "815",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bbb)(2)",
"Topic": "820",
"URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "825",
"URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.20)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "835",
"URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "835",
"URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "842",
"URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "842",
"URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(a)(3)(iii)(03)",
"Topic": "848",
"URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
},
"r267": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "850",
"URI": "https://asc.fasb.org/topic&trid=2122745"
},
"r268": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "852",
"URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r269": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "852",
"URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22(a)(1))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r270": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "852",
"URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
},
"r271": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r272": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(1)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r273": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(2)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r274": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(3)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(1)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r277": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(3)",
"Topic": "860",
"URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r278": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "910",
"URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
},
"r279": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.L)",
"Topic": "924",
"URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22(a)(2))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r280": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "926",
"URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
},
"r281": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "340",
"Topic": "928",
"URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
},
"r282": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
},
"r283": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
},
"r284": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
},
"r285": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
},
"r286": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
},
"r288": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
},
"r289": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r290": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
},
"r291": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
},
"r292": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(1)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
},
"r293": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(2)",
"Topic": "932",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
},
"r294": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "20",
"Topic": "940",
"URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
},
"r295": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r296": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r297": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(15))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r298": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r299": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(27))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r3": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "205",
"URI": "https://asc.fasb.org/topic&trid=2122149"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r300": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r301": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "360",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
},
"r302": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "405",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
},
"r303": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Subparagraph": "(c)",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
},
"r304": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
},
"r305": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "825",
"Topic": "942",
"URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
},
"r306": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r307": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r308": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r309": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(8))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
},
"r310": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r311": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(23))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r312": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(8))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r313": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(9))",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r314": {
"Name": "Accounting Standards Codification",
"Paragraph": "7A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(d)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
},
"r315": {
"Name": "Accounting Standards Codification",
"Paragraph": "29F",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
},
"r316": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r317": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(1)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r318": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(2)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r319": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(i)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
},
"r320": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(h)(2)",
"Topic": "944",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r321": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "210",
"Topic": "946",
"URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
},
"r322": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "210",
"Topic": "946",
"URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
},
"r323": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "220",
"Subparagraph": "(k)",
"Topic": "946",
"URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
},
"r324": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
"Topic": "946",
"URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
},
"r325": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "310",
"Subparagraph": "(c)",
"Topic": "976",
"URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
},
"r326": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "310",
"Subparagraph": "(b)",
"Topic": "978",
"URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
},
"r327": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "985",
"URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
},
"r328": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12"
},
"r329": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
},
"r330": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r331": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-23"
},
"r332": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r333": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "g"
},
"r334": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12, 13, 15d"
},
"r335": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "13e",
"Subsection": "4c"
},
"r336": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14d",
"Subsection": "2b"
},
"r337": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "15",
"Subsection": "d"
},
"r338": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14a",
"Subsection": "12"
},
"r339": {
"Name": "Form 10-K",
"Number": "249",
"Publisher": "SEC",
"Section": "310"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
},
"r340": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "308",
"Subsection": "a"
},
"r341": {
"Name": "Form 20-F",
"Number": "249",
"Publisher": "SEC",
"Section": "220",
"Subsection": "f"
},
"r342": {
"Name": "Form 40-F",
"Number": "249",
"Publisher": "SEC",
"Section": "240",
"Subsection": "f"
},
"r343": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1"
},
"r344": {
"Name": "Regulation S-K (SK)",
"Number": "229",
"Paragraph": "(a)",
"Publisher": "SEC",
"Section": "1402"
},
"r345": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r346": {
"Name": "Securities Act",
"Number": "230",
"Publisher": "SEC",
"Section": "405"
},
"r347": {
"Name": "Securities Act",
"Number": "230",
"Publisher": "SEC",
"Section": "425"
},
"r348": {
"Name": "Securities Act",
"Number": "7A",
"Publisher": "SEC",
"Section": "B",
"Subsection": "2"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(1))",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(10))",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(25))",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(b)(4))",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.8)",
"Topic": "220",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(d))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(f))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(k)(1))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.12-04(a))",
"Topic": "235",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
},
"r64": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "https://asc.fasb.org/topic&trid=2122369"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(1))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(16))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "55",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(18))",
"Topic": "210",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "272",
"URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
}
},
"version": "2.1"
} |
